Skip to main content

Table 2 Mean serum thymidine kinase 1 (STK1) specific activity values in different groups and comparison with blood donors

From: Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker

  

STK1 specific activity (nmol/min/mg)

   

Tumor type

N

Mean ± SD

Range (nmol/min/mg)

Comparison with blood donors

P value

MDS

22

136 ± 112

30 -515

no signifcant difference

0.635

Breast cancer

42

79 ± 69

12 -268

Yes (***)

0.0005

Prostate cancer

47

62 ± 47

11 - 183

Yes (***)

<0.0001

Blood donors

30

130 ± 62

29 - 243

  
  1. *indicates the significant difference levels (* = low, ** = medium, *** = high).